Abivax S.A. ABVX
$73.20 −$7.45 (-9.24%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $74.95 +2.39%
Open$79.01
Prev close$80.65
Day range$62.70 – $79.74
Volume14.85M
Market cap$6.41B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026 · reported in EUR
Revenue€0.00
Operating profit-€84.11M-80.9% YoY
Net profit-€117.43M-142.6% YoY
Diluted EPS-€1.47-93.4% YoY
Free cash flow-€52.10M-56.2% YoY
Operating cash flow-€51.99M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-252.3%
Return on assets-137.9%
Return on invested capital-190.2%
Current ratio5.97
Liabilities / assets20.8%
Cash & investments€410.68M
Total debt€137,000.00
Net cash (debt)€410.55M
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Operating Revenue | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Operating Expense | €84.11M | €56.23M | €246.06M | €71.65M | €80.71M |
| Selling and Admin Expenses | €26.98M | €8.03M | €72.87M | €27.69M | €27.34M |
| -Selling & Marketing Expense | €102,000.00 | €75,000.00 | €224,000.00 | €21,000.00 | €14,000.00 |
| -General & Admin Expense | €26.87M | €7.96M | €72.64M | €27.67M | €27.33M |
| Research & Development | €58.34M | €49.54M | €177.76M | €44.40M | €55.42M |
| Other Operating Expenses | -€1.20M | -€1.34M | -€4.57M | -€440,000.00 | -€2.04M |
| Operating Profit | -€84.11M | -€56.23M | -€246.06M | -€71.65M | -€80.71M |
| Net Non-Operating Interest Income (Expense) | €2.69M | €1.50M | -€52.49M | €1.22M | -€49.14M |
| Non-Operating Interest Income | €1.28M | €769,000.00 | €5.75M | €807,000.00 | €3.53M |
| Non-Operating Interest Expense | €730,000.00 | €2.54M | €28.48M | €15.27M | €4.21M |
| Total Other Finance Costs | -€2.14M | -€3.27M | €29.76M | -€15.68M | €48.46M |
| Other Income (Expense) | -€42.09M | €6.49M | -€31.71M | -€5.68M | -€23.50M |
| Gain on Sale of Security | €1.12M | €6.49M | -€27.87M | -€1.84M | -€23.50M |
| Special Income (Charges) | -€43.21M | – | -€3.84M | – | – |
| -Less:Other Special Charges | €43.21M | – | €3.84M | – | – |
| Pretax Profit | -€123.51M | -€48.24M | -€330.25M | -€76.11M | -€153.36M |
| Tax | -€6.08M | €228,000.00 | €5.85M | €5.85M | €0.00 |
| Net Profit | -€117.43M | -€48.47M | -€336.10M | -€81.96M | -€153.36M |
| Profit from Continuing Operations | -€117.43M | -€48.47M | -€336.10M | -€81.96M | -€153.36M |
| Net Income to Parent Company | -€117.43M | -€48.47M | -€336.10M | -€81.96M | -€153.36M |
| Net Income to Common Stockholders | -€117.43M | -€48.47M | -€336.10M | -€81.96M | -€153.36M |
| Basic EPS | -€1.47 | -€0.61 | -€4.83 | -€1.02 | -€2.10 |
| Diluted EPS | -€1.47 | -€0.61 | -€4.83 | -€1.02 | -€2.10 |
Balance sheet
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €462.21M | €547.14M | €584.34M | €584.34M | €652.05M |
| Total Current Assets | €427.62M | €513.22M | €551.24M | €551.24M | €619.30M |
| Cash and Cash Equivalents & Short-Term Investments | €410.68M | €491.55M | €530.38M | €530.38M | €589.70M |
| -Cash and Cash Equivalents | €387.99M | €477.42M | €516.69M | €516.69M | €589.70M |
| -Short Term Investments | €22.69M | €14.13M | €13.70M | €13.70M | – |
| Receivables | €12.42M | €10.81M | €10.50M | €10.50M | €19.66M |
| -Notes Receivable | €243,000.00 | – | €0.00 | €0.00 | €11,000.00 |
| -Taxes Receivable | €11.31M | €10.62M | €10.07M | €10.07M | €13.06M |
| -Other Receivables | €872,000.00 | €190,000.00 | €429,000.00 | €429,000.00 | €6.59M |
| Prepaid Assets | €4.39M | €10.86M | €10.37M | €10.37M | €9.93M |
| Other Current Assets | €125,000.00 | -€1,000.00 | – | – | -€1,000.00 |
| Total Non-Current Assets | €34.59M | €33.92M | €33.10M | €33.10M | €32.76M |
| Net PPE | €1.52M | €1.78M | €2.09M | €2.09M | €1.91M |
| -Gross PPE | €4.46M | €4.34M | €4.27M | €4.27M | €3.92M |
| -Accumulated Depreciation | -€2.94M | -€2.56M | -€2.18M | -€2.18M | -€2.00M |
| Non Current Accounts Receivables | €2.14M | €1.14M | – | – | – |
| Non-Current Prepaid Assets | €5.90M | €5.98M | €5.98M | €5.98M | €5.69M |
| Goodwill and Other Intangible Assets | €25.02M | €25.02M | €25.02M | €25.02M | €25.02M |
| -Goodwill | €18.42M | €18.42M | €18.42M | €18.42M | €18.42M |
| -Other Intangible Assets | €6.61M | €6.61M | €6.61M | €6.61M | €6.61M |
| Total Liabilities | €95.94M | €117.55M | €129.14M | €129.14M | €140.81M |
| Total Current Liabilities | €71.69M | €62.23M | €63.02M | €63.02M | €78.76M |
| Payables | €21.28M | €12.26M | €44.69M | €44.69M | €17.63M |
| -Accounts Payable | €18.26M | €9.96M | €37.55M | €37.55M | €14.36M |
| -Total Tax Payable | €177,000.00 | €164,000.00 | €7.14M | €7.14M | €259,000.00 |
| -Other Payable | €2.84M | €2.13M | – | – | €3.02M |
| Current Accrued Expenses | €20.75M | €19.55M | – | – | €15.66M |
| Short-Term Debt and Capital Lease Obligation | €1.08M | €1.10M | €1.30M | €1.30M | €29.40M |
| -Current Capital Lease Obligation | €1.08M | €1.10M | €1.30M | €1.30M | €938,000.00 |
| Current Provisions | €23.91M | €18.13M | €17.03M | €17.03M | €11.41M |
| Total Non-Current Liabilities | €24.25M | €55.32M | €66.12M | €66.12M | €62.05M |
| Long Term Debt and Capital Lease Obligation | €137,000.00 | €346,000.00 | €554,000.00 | €554,000.00 | €16.49M |
| -Long Term Capital Lease Obligation | €137,000.00 | €346,000.00 | €554,000.00 | €554,000.00 | €611,000.00 |
| Non-Current Liabilities | €23.42M | €15.49M | €28.85M | €28.85M | €16.62M |
| Non-Current Deferred Liabilities | €0.00 | €6.08M | €5.85M | €5.85M | – |
| Employee Benefits | €696,000.00 | €638,000.00 | €627,000.00 | €627,000.00 | €844,000.00 |
| Other Non-Current Liabilities | -€1,000.00 | €32.76M | €30.24M | €30.24M | €28.10M |
| Total Equity | €366.27M | €429.59M | €455.21M | €455.21M | €511.24M |
| Stockholders' Equity | €366.27M | €429.59M | €455.21M | €455.21M | €511.24M |
| Capital Stock | €798,000.00 | €793,000.00 | €785,000.00 | €785,000.00 | €778,000.00 |
| -Common Stock | €798,000.00 | €793,000.00 | €785,000.00 | €785,000.00 | €778,000.00 |
| Additional Paid-In Capital | €1.23B | €1.19B | €1.19B | €1.19B | €1.18B |
| Retained Earnings | -€864.96M | -€764.31M | -€738.48M | -€738.48M | -€669.81M |
| Gains/Losses Not Affecting Retained Earnings | €1.77M | €2.03M | €2.31M | €2.31M | €743,000.00 |
| Other Non-Current Assets | – | €1,000.00 | -€1,000.00 | -€1,000.00 | – |
| Investments and Advances | – | – | €0.00 | €0.00 | €126,000.00 |
| Current Deferred Liabilities | – | – | €0.00 | €0.00 | – |
| Derivative Product Liabilities | – | – | €0.00 | €0.00 | €0.00 |
| -Available for Sale Securities | – | – | – | – | €126,000.00 |
| -Current Debt | – | – | – | – | €28.46M |
| -Long Term Debt | – | – | – | – | €15.88M |
Cash flow
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | -€51.99M | -€50.52M | -€161.13M | -€23.23M | -€71.28M |
| Net cash flow from continuing operations | -€51.99M | -€50.52M | -€161.13M | -€23.23M | -€71.28M |
| Net Income from Continuing Operations | -€117.43M | -€48.47M | -€336.10M | -€81.96M | -€153.36M |
| Gain/Loss from Continuing Operations | €31,000.00 | €34,000.00 | €62.27M | -€171,000.00 | €63.29M |
| Depreciation & Depletion & Amortization | €374,000.00 | €367,000.00 | €1.07M | €276,000.00 | €272,000.00 |
| Deferred Tax | -€6.08M | €228,000.00 | €5.85M | – | – |
| Other Non-Cash Items | €39.43M | -€7.98M | €22.03M | €4.91M | €9.11M |
| Change in Working Capital | €1.24M | -€4.98M | €3.65M | -€9.73M | -€2.08M |
| -Change in Receivables | -€1.54M | -€3.48M | €7.04M | €9.34M | -€4.59M |
| -Change in Payables and Accrued Expense | €2.85M | -€1.49M | -€4.10M | €6.73M | -€23.26M |
| Net cash flow from investing | €971,000.00 | €495,000.00 | -€8.19M | -€12.74M | €3.28M |
| Net Cash Flow from Continuing Investing Activities | €971,000.00 | €495,000.00 | -€8.19M | -€12.74M | €3.28M |
| Net PPE Purchase and Sale | -€112,000.00 | -€54,000.00 | -€142,000.00 | -€87,000.00 | €8,000.00 |
| Net Business Purchase and Sale | €6,000.00 | €37,000.00 | – | – | €40,000.00 |
| Financing Cash Flow | -€39.35M | €73,000.00 | €547.31M | -€39.55M | €603.46M |
| Net Cash Flow from Continuing Financing Activities | -€39.35M | €73,000.00 | €547.31M | -€39.55M | €603.46M |
| Net Issuance Payments Of Debt | -€104,000.00 | -€389,000.00 | -€59.53M | -€40.76M | -€5.74M |
| Cash Dividends Paid | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Ending Cash Balance | €387.99M | €477.42M | €516.69M | €516.69M | €589.70M |
| Net Change in Cash | -€84.95M | -€49.95M | €382.72M | -€71.71M | €535.91M |
| Beginning Cash Balance | €477.42M | €516.69M | €144.22M | €589.70M | €60.95M |
| Effect of Exchange Rate Changes | -€4.48M | €10.69M | -€10.25M | -€1.31M | -€7.16M |
| Free Cash Flow | -€52.10M | -€50.57M | -€161.27M | -€23.32M | -€71.28M |
| Net Investment Purchase and Sale | – | €0.00 | – | – | – |
| Proceeds from Stock Option Exercised | – | €475,000.00 | €5.82M | €3.15M | – |
| -Change In Other Working Capital | – | – | €710,000.00 | -€25.81M | €25.77M |
| Net Intangibles Purchase and Sale | – | – | €0.00 | €0.00 | – |
| Net Other Investing Changes | – | – | -€13.58M | -€13.47M | -€224,000.00 |
| Net Common Stock Issuance | – | – | €648.12M | €40.04M | – |
| Net Other Financing Charges | – | – | -€40.61M | -€40.92M | €1,000.00 |
No comments yet — be the first to weigh in on ABVX.
Sign in to join the discussion.